Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy
Top Cited Papers
Open Access
- 1 March 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (5) , 686-693
- https://doi.org/10.1086/319211
Abstract
To assess the mortality and resource utilization that results from acute renal failure associated with amphotericin B therapy, 707 adult admissions iKeywords
This publication has 33 references indexed in Scilit:
- Liposomal Amphotericin BDrugs, 1998
- Systemic Antifungal AgentsDrug Safety, 1998
- Administration of amphotericin B in lipid emulsion decreases nephrotoxicityCritical Care Medicine, 1996
- Candidemia in a Tertiary Care Hospital: Epidemiology, Risk Factors, and Predictors of MortalityClinical Infectious Diseases, 1992
- Drug-Induced Nephrotoxicity Aetiology, Clinical Features and ManagementDrug Safety, 1991
- Sodium Protects Against Nephrotoxicity in Patients Receiving Amphotericin BThe Lancet Healthy Longevity, 1989
- Drug NephrotoxicityAnnual Review of Pharmacology and Toxicology, 1988
- Fungemia in a Cancer Hospital: Changing Frequency, Earlier Onset, and Results of TherapyClinical Infectious Diseases, 1985
- Candida Infections in Surgical PatientsAnnals of Surgery, 1983
- Amphotericin B nephrotoxicity: Increased renal resistance and tubule permeabilityKidney International, 1982